UiPath Analyst Outlook Split
Needham Reitrates Buy Rating on UiPath While Other Analysts Remain Cautious
Anonymous
Key Points
1
UiPath’s automation portfolio includes robotic process automation (RPA), APIs and AI, which the article says it uses to automate repetitive tasks across industries.
2
The article noted that UiPath’s five most recent analyst notes published over the prior 30 days had price targets ranging from $15 to $22.
3
Truist’s rationale linked its cautious rating to current market conditions and competition, alongside uncertainty about macroeconomic conditions and execution risks.
Analyst opinion on UiPath remains split as the automation software company faces mixed signals from Wall Street. Needham reiterated a Buy rating with a $22 price target, while BMO Capital, Canaccord Genuity, and Truist Securities maintained more cautious Hold or Market Perform ratings with targets ranging from $14 to $15. UiPath closed September 22 at $13.25, meaning the Street's outlook ranges from barely positive to 66% upside.
The company posted solid Q3 results: earnings of $0.15 per share matched expectations, while revenue hit $410.26 million, beating forecasts and growing 13.3% year over year. Yet analysts worry that competition, macroeconomic headwinds, and execution risks could limit gains despite UiPath's strong automation portfolio spanning robotic process automation, APIs, and AI tools.
Needham Sees Upside as Other Firms Stay Cautious
Needham stands alone with bullish conviction, keeping its $22 target intact and rating the stock a Buy. That implies 66% upside from the current price. Meanwhile, BMO Capital lowered its target from $18 to $15, citing platform uncertainty and maintaining a Market Perform rating. Canaccord Genuity cut its target from $17 to $14 and kept a Hold rating, offering just 5.6% upside.
Automation Portfolio Powers Growth, But Risks Loom
UiPath's appeal lies in its breadth. The company offers robotic process automation (RPA) to handle repetitive tasks, plus APIs and AI tools that expand its reach across industries. Analysts credit this portfolio mix with opening doors in regulated sectors where growth may be strongest. But execution must be flawless.
Truist Securities maintained its Hold rating at a $14 target, signaling just 5.7% upside. The firm linked its caution to current market conditions, stiff competition, and broad macroeconomic uncertainty. That same pattern shows up across the cautious camp: growth is real, but headwinds are real too.
Wall Street's Price Targets Show Deep Disagreement
Over the prior 30 days, analyst price targets ranged from $15 to $22 — a $7 spread that reflects genuine uncertainty about UiPath's path forward. TD Cowen also joined the cautious chorus, lowering its target to $15 and keeping a Hold. The gap between bulls and bears suggests the market hasn't reached consensus on whether UiPath can navigate competition and macro risks while scaling its automation platform.
Sentiment
Mostly PositiveNEGATIVENEUTRALPOSITIVE
Publishers
14
Articles
32
Reach
46
A
AnonymousAuthor
